IRIS
RAFANIELLO, Concetta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.270
NA - Nord America 4.543
AS - Asia 3.129
SA - Sud America 472
Continente sconosciuto - Info sul continente non disponibili 217
AF - Africa 35
OC - Oceania 3
AN - Antartide 1
Totale 15.670
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 4.799
US - Stati Uniti d'America 4.432
SG - Singapore 1.006
CN - Cina 732
IT - Italia 696
IE - Irlanda 673
VN - Vietnam 425
BR - Brasile 389
HK - Hong Kong 388
GB - Regno Unito 278
DE - Germania 256
UA - Ucraina 174
IN - India 135
KR - Corea 117
JP - Giappone 113
FI - Finlandia 74
TR - Turchia 58
SE - Svezia 57
BD - Bangladesh 55
CA - Canada 54
GR - Grecia 52
FR - Francia 39
AR - Argentina 31
NL - Olanda 29
AT - Austria 24
BE - Belgio 21
MX - Messico 20
ID - Indonesia 19
EC - Ecuador 18
ES - Italia 16
IQ - Iraq 16
ZA - Sudafrica 13
CZ - Repubblica Ceca 11
JM - Giamaica 11
IR - Iran 10
LT - Lituania 10
PL - Polonia 10
VE - Venezuela 9
IL - Israele 8
PK - Pakistan 8
CO - Colombia 7
EE - Estonia 7
KG - Kirghizistan 7
CH - Svizzera 6
DK - Danimarca 6
PY - Paraguay 6
RO - Romania 6
RS - Serbia 6
MA - Marocco 5
PE - Perù 5
SA - Arabia Saudita 5
AL - Albania 4
BB - Barbados 4
CL - Cile 4
DO - Repubblica Dominicana 4
HN - Honduras 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
CR - Costa Rica 3
EG - Egitto 3
HR - Croazia 3
HU - Ungheria 3
NP - Nepal 3
SV - El Salvador 3
TN - Tunisia 3
AZ - Azerbaigian 2
BO - Bolivia 2
DZ - Algeria 2
ET - Etiopia 2
JO - Giordania 2
KZ - Kazakistan 2
LV - Lettonia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PR - Porto Rico 2
PT - Portogallo 2
QA - Qatar 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AQ - Antartide 1
AU - Australia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
HT - Haiti 1
KE - Kenya 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MN - Mongolia 1
MU - Mauritius 1
MY - Malesia 1
NI - Nicaragua 1
OM - Oman 1
SC - Seychelles 1
Totale 15.449
Salva come PNG Salva come JPEG
Città #
Moscow 1.765
Dublin 665
San Jose 597
Singapore 513
Santa Clara 392
Hong Kong 383
Ashburn 363
Jacksonville 268
Chandler 256
Council Bluffs 213
Beijing 146
Seoul 114
Ho Chi Minh City 109
Hefei 102
Hanoi 97
Naples 90
Ann Arbor 88
Milan 86
Princeton 76
Aversa 68
Roxbury 67
Dong Ket 66
New York 66
Medford 60
Bremen 57
Bengaluru 54
Memphis 51
Woodbridge 50
Munich 48
Orem 47
Dallas 46
Los Angeles 43
Düsseldorf 40
Wilmington 40
Atlanta 37
Caserta 37
The Dalles 32
São Paulo 30
Dearborn 28
Rome 27
Cambridge 26
Nanjing 26
Da Nang 25
Chennai 24
Boardman 23
Mountain View 23
Des Moines 21
Brussels 20
San Francisco 20
Genoa 18
Hanover 18
Toronto 18
London 17
Manchester 17
Amsterdam 16
Kunming 16
San Mateo 16
Helsinki 15
Jinan 15
Messina 15
Miano 15
Auburn Hills 14
Frankfurt am Main 14
Chicago 13
Haiphong 13
Jakarta 13
Curitiba 12
Napoli 12
Nuremberg 12
Turku 12
Biên Hòa 11
Brno 11
Brooklyn 11
Columbus 11
Guangzhou 11
Phủ Lý 11
Vienna 11
Brasília 10
Montreal 10
Changsha 9
Houston 9
Mumbai 9
Nanchang 9
New Delhi 9
Pomigliano d'Arco 9
Tokyo 9
Belo Horizonte 8
Falkenstein 8
Guarulhos 8
Johannesburg 8
Kingston 8
Mexico City 8
Philadelphia 8
Phoenix 8
Rio de Janeiro 8
Salerno 8
Hillsboro 7
Hải Dương 7
Miami 7
Newark 7
Totale 8.104
Salva come PNG Salva come JPEG
Nome #
Disentangling a Thorny Issue: Myocarditis and Pericarditis Post COVID-19 and Following mRNA COVID-19 Vaccines 383
Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance 358
Adverse drug reactions and gender differences: What changes in drug safety? 239
Bisphosphonate-related osteonecrosis of the jaw: an italian post-marketing surveillance analysis 206
Predictors of mortality in atypical antipsychotic-treated community-dwelling elderly patients with behavioural and psychological symptoms of dementia: a prospective population-based cohort study from Italy 201
Colorectal cancer association with metabolic syndrome and its components: a systematic review with meta-analysis 196
Campania Region (Italy) spontaneous reporting system and preventability assessment through a case-by-case approach: a pilot study on psychotropic drugs 195
Contrast media-induced nephropathy: how has Italy contributed in the past 30 years? A systematic review 190
Safety profile of anticancer and immune-modulating biotech drugs used in a real world setting in Campania Region (Italy): BIO-Cam observational study 189
Effects of chronic administration of β-blockers on airway responsiveness in a murine model of heart failure. 188
Cardiorespiratory effects of change in posture after spinal anesthesia with hyperbaric bupivacaine 187
Campania preventability assessment committee (Italy): A focus on the preventability of non-steroidal anti-inflammatory drugs' adverse drug reactions 187
Survival from coma induced by an intentional 36-g overdose of extended-release quetiapine 184
Effects of chronic treatment with the new ultra-long-acting β2 -adrenoceptor agonist indacaterol alone or in combination with the β1 -adrenoceptor blocker metoprolol on cardiac remodelling. 182
Trends in the prescription of antidiabetic medications from 2009 to 2012 in a general practice of Southern Italy: A population-based study. 179
Campania preventability assessment committee: a focus on the preventability of the contrast media adverse drug reactions 178
Complete resistance after maximal dose of rocuronium 177
Metabolic syndrome and postmenopausal breast cancer: systematic review and meta-analysis 173
Medication adherence and the use of new pharmaceutical formulations: The case of levothyroxine 171
Angiotensin receptor/Neprilysin inhibitor effects in CRTd non-responders: From epigenetic to clinical beside 170
Dipeptidyl Peptidase (DPP)-4 Inhibitor-Induced Arthritis/Arthralgia: A Review of Clinical Cases 170
Targeting high glucose-induced epigenetic modifications at cardiac level: the role of SGLT2 and SGLT2 inhibitors 169
Atomoxetine in the treatment of attention deficit hyperactivity disorder and suicidal ideation 167
Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients: An observational study in real-life settings 166
Analysis of fatal adverse drug events recorded in several Italian emergency departments (the MEREAFaPS study) 164
The Reporting Frequency of Ketoacidosis Events with Dapagliflozin from the European Spontaneous Reporting System: The DAPA-KETO Study 163
Improvement of patient adverse drug reaction reporting through a community pharmacist-based intervention in the Campania region of Italy 161
Pregnancy Recommendations Solely Based on Preclinical Evidence Should Be Integrated with Real-World Evidence: A Disproportionality Analysis of Certolizumab and Other TNF-Alpha Inhibitors Used in Pregnant Patients with Psoriasis 160
Association between Sex-Related ALOX5 Gene Polymorphisms and Lung Atopy Risk 160
Pattern of statin use in southern Italian primary care: Can prescription databases be used for monitoring long-term adherence to the treatment? 158
Effects of ranolazine in a model of doxorubicin-induced left ventricle diastolic dysfunction 156
Cardiac Events Potentially Associated to Remdesivir: An Analysis from the European Spontaneous Adverse Event Reporting System 156
Safety Monitoring of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years by Using EudraVigilance Pharmacovigilance Database: The CoVaxChild Study 155
Hypogammaglobulinemia in patients with multiple sclerosis receiving disease modifying therapies: disproportionality analysis using the EudraVigilance database 154
Vitamin D deficiency in type 2 diabetic patients with hypogonadism. 153
Did the new Italian law on mandatory vaccines affect adverse event Following immunization's reporting? A pharmacovigilance study in Southern Italy 153
Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study 153
Late relapse after CAR-T cell therapy for adult patients with hematologic malignancies: A definite evidence from systematic review and meta-analysis on individual data 152
COVID-19 and atrial fibrillation: Intercepting lines 152
Neurological Manifestations Related to Immune Checkpoint Inhibitors: Reverse Translational Research by Using the European Real-World Safety Data 151
COVID-19 Vaccines and Atrial Fibrillation: Analysis of the Post-Marketing Pharmacovigilance European Database 148
Uncovering prognostic biomarkers through a pharmacovigilance study: the case of RDW 148
Risk of gastrointestinal complications associated to NSAIDs, low-dose aspirin and their combinations: Results of a pharmacovigilance reporting system 147
Do immune checkpoint inhibitors share the same pharmacological feature in the risk of cardiac arrhythmias? 146
Did the COVID-19 Pandemic Affect Contrast Media-Induced Adverse Drug Reaction’s Reporting? A Pharmacovigilance Study in Southern Italy 146
Drug use and upper gastrointestinal complications in children: a case-control study 145
Persistence in therapy with risperidone and aripiprazole in pediatric outpatients: A 2-year naturalistic comparison 145
Current pharmacological treatments for COVID-19: What's next? 145
Hypoglycemia, polycythemia and hyponatremia in a newborn exposed to nebivolol during pregnancy. 144
Italian Emergency Department Visits and Hospitalizations for Outpatients’ Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study) 144
Disclosing negative trial results – procedure 142
Deficit of glucocorticoid-induced leucine zipper amplifies angiotensin-induced cardiomyocyte hypertrophy and diastolic dysfunction 142
The importance of Pharmacovigilance for the drug safety: Focus on cardiovascular profile of incretin-based therapy 141
Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary 140
Stevens-johnson syndrome associated with drugs and vaccines in children: a case-control study 140
Hyaluronic acid-based fillers in patients with autoimmune inflammatory diseases 139
Vaccine effectiveness against severe laboratory-confirmed influenza in children: Results of two consecutive seasons in Italy 139
Multisystem Inflammatory Syndrome in Children Following COVID-19 Vaccination: A Sex-Stratified Analysis of the VAERS Database Using Brighton Collaboration Criteria 139
Second generation antipsychotics in ‘real-life’ paediatric patients. Adverse drug reactions and clinical outcomes of drug switch 138
A Pharmacovigilance Study on the Safety of Axicabtagene Ciloleucel Based on Spontaneous Reports from the EudraVigilance Database 136
Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials 135
Contribution of Italian clinical research for contrast media-induced nonrenal adverse drug reactions over the last three decades: A systematic review 135
Utilizing clinical pharmacology in the drug repurposing arena: a look into COVID-19 134
Hospital consumption of antibiotics at the Policlinico Hospital of the Second University of Naples: results of retrospective data collection 133
Safety of attention-deficit/hyperactivity disorder medications in children: an intensive pharmacosurveillance monitoring study. 132
Alginate-Based Composites for Corneal Regeneration: The Optimization of a Biomaterial to Overcome Its Limits 131
Effects of SGLT2i therapy on cardiac electrophysiological properties and arrhythmias in diabetic patients with implantable cardiac defibrillator 131
The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19 131
Sodium-glucose cotransporter–2 (SGLT2) inhibitors and the reporting of falls and fractures: an european pharmacovigilance analysis 130
miRNA Signatures in Alveolar Macrophages Related to Cigarette Smoke: Assessment and Bioinformatics Analysis 126
Risk of acute and serious liver injury associated to nimesulide and other NSAIDs: data from drug-induced liver injury case–control study in Italy 125
Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database 125
Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance 124
Effectiveness and safety of the A-H1N1 vaccine in children: a hospital-based case-control study 121
Rational use of antibiotics for the management of children's respiratory tract infections in the ambulatory setting: An evidence-based consensus by the Italian Society of Preventive and Social Pediatrics 121
PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database 121
SAFETY AND TOLERABILITY OF ADHD MEDICATIONS: AN INTENSIVE MONITORING PROGRAMME IN THE CAMPANIA REGION 120
New era in treatment options of chronic hepatitis C: focus on safety of new direct-acting antivirals (DAAs) 120
DPP-4 inhibitors: Pharmacological differences and their clinical implications 118
Indications of newer and older anti-epileptic drug use: Findings from a southern Italian general practice setting from 2005-2011 116
Therapeutic strategies to fight COVID-19: Which is the status artis? 116
Drugs approved for the treatment of multiple sclerosis: review of their safety profile 115
Surveillance of adverse events following immunization related to human papillomavirus vaccines: 12 years of vaccinovigilance in Southern Italy 115
Renin-angiotensin system and coronavirus disease 2019: A narrative review 115
Drug Utilization and Measurement of Medication Adherence: A Real World Study of Psoriasis in Italy 115
The predictive value of ABCB1, ABCG2, CYP3A4/5 and CYP2D6 polymorphisms for risperidone and aripiprazole plasma concentrations and the occurrence of adverse drug reactions 114
Preventable statin adverse reactions and therapy discontinuation. What can we learn from the spontaneous reporting system? 114
Pillars and Pitfalls of the New Pharmacovigilance legislation: Consequences for the identification of adverse drug reactions deriving from abuse, misuse, overdose, occupational exposure, and medication errors 113
Drugs-induced pathological gambling: An analysis of italian spontaneous reporting system 113
No substantial gender differences in suspected adverse reactions to ACE inhibitors and ARBs: results from spontaneous reporting system in Campania Region 112
Strengths, weaknesses and future challenges of biosimilars’ development. An opinion on how to improve the knowledge and use of biosimilars in clinical practice 112
Risk of hospitalisation associated with benzodiazepines and z-drugs in Italy: a nationwide multicentre study in emergency departments 112
Quinolones-Induced Musculoskeletal, Neurological, and Psychiatric ADRs: A Pharmacovigilance Study Based on Data From the Italian Spontaneous Reporting System 108
Tisagenlecleucel in children and young adults: Reverse translational research by using real‐world safety data 107
Preventable cases of oral anticoagulant-induced bleeding: Data from the spontaneous reporting system 105
We Really Need Clear Guidelines and Recommendations for Safer and Proper Use of Aripiprazole and Risperidone in a Pediatric Population: Real-World Analysis of EudraVigilance Database 104
The efficacy and the safety of Eltrombopag in pediatric patients with Severe Aplastic Anemia: a systematic review 103
Weight-Change Trajectories of Pediatric Outpatients Treated with Risperidone or Aripiprazole in a Naturalistic Setting 101
Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems 101
Pharmacological, Technological, and Digital Innovative Aspects in Rhinology 100
Totale 14.884
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.539
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.539
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022463 0 0 0 5 172 23 13 16 23 25 32 154
2022/20231.279 127 38 18 94 115 89 12 64 626 15 56 25
2023/2024597 43 16 44 41 173 44 13 68 13 17 39 86
2024/20251.781 14 40 25 52 221 255 315 154 244 151 132 178
2025/20268.338 351 421 357 369 703 4.429 313 544 259 226 256 110
2026/20271.575 407 295 400 473 0 0 0 0 0 0 0 0
Totale 15.670